Skip to main content
icon for Alamar Biosciences IPO Closing Market Cap

Alamar Biosciences IPO Closing Market Cap

icon for Alamar Biosciences IPO Closing Market Cap

Alamar Biosciences IPO Closing Market Cap

1.3B+ 100.0%

<0.9B <1%

0.9B–1.0B <1%

1.0B–1.1B <1%

Polymarket

$5,969 Vol.

1.3B+ 100.0%

<0.9B <1%

0.9B–1.0B <1%

1.0B–1.1B <1%

Polymarket

$5,969 Vol.

<0.9B

$943 Vol.

No

0.9B–1.0B

$834 Vol.

No

1.0B–1.1B

$822 Vol.

No

1.1B–1.2B

$741 Vol.

No

1.2B–1.3B

$570 Vol.

No

1.3B+

$1,621 Vol.

Yes

No IPO before June 2026

$438 Vol.

No

This market will resolve based on Alamar Biosciences’ market capitalization at the closing price on its first day of trading. As of market creation, the IPO is scheduled to price on April 17 (ET). If no such IPO occurs by May 31, 2026, 11:59 PM ET, the market will resolve to "No IPO before June 2026". Market capitalization expresses the monetary value of a company’s outstanding shares, stated in its pricing currency. It is calculated as the total number of outstanding shares, multiplied by the official closing share price of the publicly traded class on the first trading day. If necessary, to accurately capture the company’s total market capitalization, rather than a stock-class-specific market capitalization, the calculation will include all outstanding share classes and apply any stated conversion ratios to the publicly traded class. Where no conversion right exists, such shares will be counted at their stated outstanding amount without discount, unless official filings explicitly specify differently. The number of outstanding shares will be determined from official company filings or disclosures (e.g., SEC filings). The closing share price on the first trading day will be determined from the primary exchange’s official listing page. If the relevant value falls exactly between two brackets, this market will resolve to the higher range bracket. The primary resolution source for this market will be official company filings and the primary exchange’s official listing page. The market capitalization will be determined through appropriate calculation using the total outstanding shares and the closing price from the first day of trading. In the event of an interruption in the normal trading session on the specified company’s first day of trading (e.g., a circuit breaker or half-day), the market will resolve according to the official closing price of the abbreviated session. If no such official closing price is published, the market will resolve according to the next trading day on which an official closing price is published, treating that day as the first day of trading for the purposes of this market.

This market will resolve based on Alamar Biosciences’ market capitalization at the closing price on its first day of trading.

As of market creation, the IPO is scheduled to price on April 17 (ET). If no such IPO occurs by May 31, 2026, 11:59 PM ET, the market will resolve to "No IPO before June 2026".

Market capitalization expresses the monetary value of a company’s outstanding shares, stated in its pricing currency.

It is calculated as the total number of outstanding shares, multiplied by the official closing share price of the publicly traded class on the first trading day.

If necessary, to accurately capture the company’s total market capitalization, rather than a stock-class-specific market capitalization, the calculation will include all outstanding share classes and apply any stated conversion ratios to the publicly traded class. Where no conversion right exists, such shares will be counted at their stated outstanding amount without discount, unless official filings explicitly specify differently.

The number of outstanding shares will be determined from official company filings or disclosures (e.g., SEC filings). The closing share price on the first trading day will be determined from the primary exchange’s official listing page.

If the relevant value falls exactly between two brackets, this market will resolve to the higher range bracket.

The primary resolution source for this market will be official company filings and the primary exchange’s official listing page. The market capitalization will be determined through appropriate calculation using the total outstanding shares and the closing price from the first day of trading.

In the event of an interruption in the normal trading session on the specified company’s first day of trading (e.g., a circuit breaker or half-day), the market will resolve according to the official closing price of the abbreviated session. If no such official closing price is published, the market will resolve according to the next trading day on which an official closing price is published, treating that day as the first day of trading for the purposes of this market.
ভলিউম
$5,969
শেষ তারিখ
Apr 17, 2026
মার্কেট ওপেন হয়েছে
Apr 14, 2026, 5:05 PM ET
This market will resolve based on Alamar Biosciences’ market capitalization at the closing price on its first day of trading. As of market creation, the IPO is scheduled to price on April 17 (ET). If no such IPO occurs by May 31, 2026, 11:59 PM ET, the market will resolve to "No IPO before June 2026". Market capitalization expresses the monetary value of a company’s outstanding shares, stated in its pricing currency. It is calculated as the total number of outstanding shares, multiplied by the official closing share price of the publicly traded class on the first trading day. If necessary, to accurately capture the company’s total market capitalization, rather than a stock-class-specific market capitalization, the calculation will include all outstanding share classes and apply any stated conversion ratios to the publicly traded class. Where no conversion right exists, such shares will be counted at their stated outstanding amount without discount, unless official filings explicitly specify differently. The number of outstanding shares will be determined from official company filings or disclosures (e.g., SEC filings). The closing share price on the first trading day will be determined from the primary exchange’s official listing page. If the relevant value falls exactly between two brackets, this market will resolve to the higher range bracket. The primary resolution source for this market will be official company filings and the primary exchange’s official listing page. The market capitalization will be determined through appropriate calculation using the total outstanding shares and the closing price from the first day of trading. In the event of an interruption in the normal trading session on the specified company’s first day of trading (e.g., a circuit breaker or half-day), the market will resolve according to the official closing price of the abbreviated session. If no such official closing price is published, the market will resolve according to the next trading day on which an official closing price is published, treating that day as the first day of trading for the purposes of this market.

ফলাফল প্রস্তাবিত: No

কোনো ডিসপিউট নেই

চূড়ান্ত ফলাফল: No

This market will resolve based on Alamar Biosciences’ market capitalization at the closing price on its first day of trading. As of market creation, the IPO is scheduled to price on April 17 (ET). If no such IPO occurs by May 31, 2026, 11:59 PM ET, the market will resolve to "No IPO before June 2026". Market capitalization expresses the monetary value of a company’s outstanding shares, stated in its pricing currency. It is calculated as the total number of outstanding shares, multiplied by the official closing share price of the publicly traded class on the first trading day. If necessary, to accurately capture the company’s total market capitalization, rather than a stock-class-specific market capitalization, the calculation will include all outstanding share classes and apply any stated conversion ratios to the publicly traded class. Where no conversion right exists, such shares will be counted at their stated outstanding amount without discount, unless official filings explicitly specify differently. The number of outstanding shares will be determined from official company filings or disclosures (e.g., SEC filings). The closing share price on the first trading day will be determined from the primary exchange’s official listing page. If the relevant value falls exactly between two brackets, this market will resolve to the higher range bracket. The primary resolution source for this market will be official company filings and the primary exchange’s official listing page. The market capitalization will be determined through appropriate calculation using the total outstanding shares and the closing price from the first day of trading. In the event of an interruption in the normal trading session on the specified company’s first day of trading (e.g., a circuit breaker or half-day), the market will resolve according to the official closing price of the abbreviated session. If no such official closing price is published, the market will resolve according to the next trading day on which an official closing price is published, treating that day as the first day of trading for the purposes of this market.

This market will resolve based on Alamar Biosciences’ market capitalization at the closing price on its first day of trading.

As of market creation, the IPO is scheduled to price on April 17 (ET). If no such IPO occurs by May 31, 2026, 11:59 PM ET, the market will resolve to "No IPO before June 2026".

Market capitalization expresses the monetary value of a company’s outstanding shares, stated in its pricing currency.

It is calculated as the total number of outstanding shares, multiplied by the official closing share price of the publicly traded class on the first trading day.

If necessary, to accurately capture the company’s total market capitalization, rather than a stock-class-specific market capitalization, the calculation will include all outstanding share classes and apply any stated conversion ratios to the publicly traded class. Where no conversion right exists, such shares will be counted at their stated outstanding amount without discount, unless official filings explicitly specify differently.

The number of outstanding shares will be determined from official company filings or disclosures (e.g., SEC filings). The closing share price on the first trading day will be determined from the primary exchange’s official listing page.

If the relevant value falls exactly between two brackets, this market will resolve to the higher range bracket.

The primary resolution source for this market will be official company filings and the primary exchange’s official listing page. The market capitalization will be determined through appropriate calculation using the total outstanding shares and the closing price from the first day of trading.

In the event of an interruption in the normal trading session on the specified company’s first day of trading (e.g., a circuit breaker or half-day), the market will resolve according to the official closing price of the abbreviated session. If no such official closing price is published, the market will resolve according to the next trading day on which an official closing price is published, treating that day as the first day of trading for the purposes of this market.
ভলিউম
$5,969
শেষ তারিখ
Apr 17, 2026
মার্কেট ওপেন হয়েছে
Apr 14, 2026, 5:05 PM ET
This market will resolve based on Alamar Biosciences’ market capitalization at the closing price on its first day of trading. As of market creation, the IPO is scheduled to price on April 17 (ET). If no such IPO occurs by May 31, 2026, 11:59 PM ET, the market will resolve to "No IPO before June 2026". Market capitalization expresses the monetary value of a company’s outstanding shares, stated in its pricing currency. It is calculated as the total number of outstanding shares, multiplied by the official closing share price of the publicly traded class on the first trading day. If necessary, to accurately capture the company’s total market capitalization, rather than a stock-class-specific market capitalization, the calculation will include all outstanding share classes and apply any stated conversion ratios to the publicly traded class. Where no conversion right exists, such shares will be counted at their stated outstanding amount without discount, unless official filings explicitly specify differently. The number of outstanding shares will be determined from official company filings or disclosures (e.g., SEC filings). The closing share price on the first trading day will be determined from the primary exchange’s official listing page. If the relevant value falls exactly between two brackets, this market will resolve to the higher range bracket. The primary resolution source for this market will be official company filings and the primary exchange’s official listing page. The market capitalization will be determined through appropriate calculation using the total outstanding shares and the closing price from the first day of trading. In the event of an interruption in the normal trading session on the specified company’s first day of trading (e.g., a circuit breaker or half-day), the market will resolve according to the official closing price of the abbreviated session. If no such official closing price is published, the market will resolve according to the next trading day on which an official closing price is published, treating that day as the first day of trading for the purposes of this market.

ফলাফল প্রস্তাবিত: No

কোনো ডিসপিউট নেই

চূড়ান্ত ফলাফল: No

বাহ্যিক লিংক থেকে সাবধান।

সচরাচর জিজ্ঞাসা

"Alamar Biosciences IPO Closing Market Cap" হলো Polymarket-এ 7 সম্ভাব্য ফলাফলসহ একটি প্রেডিকশন মার্কেট যেখানে ট্রেডাররা কী ঘটবে বলে বিশ্বাস করে তার ভিত্তিতে শেয়ার কেনাবেচা করে। বর্তমান শীর্ষ ফলাফল "1.3B+" 100%-এ, তারপর "<0.9B" 0%-এ। দাম রিয়েল-টাইম ক্রাউড-সোর্সড সম্ভাবনা প্রতিফলিত করে। মার্কেট রেজোলিউশনে সঠিক ফলাফলের শেয়ার প্রতিটি $1-এ রিডিমযোগ্য।

"Alamar Biosciences IPO Closing Market Cap" Polymarket-এ একটি নতুন তৈরি মার্কেট, Apr 14, 2026-এ লঞ্চ হয়েছে। একটি নতুন মার্কেট হিসেবে, এটি প্রথম ট্রেডারদের মধ্যে একজন হয়ে অডস সেট করার ও মার্কেটের প্রাথমিক মূল্য সংকেত প্রতিষ্ঠা করার সুযোগ। সময়ের সাথে মার্কেট গতি পেলে ভলিউম ও ট্রেডিং অ্যাক্টিভিটি ট্র্যাক করতে এই পেজ বুকমার্ক করতে পারেন।

"Alamar Biosciences IPO Closing Market Cap"-এ ট্রেড করতে, এই পেজে তালিকাভুক্ত 7 উপলব্ধ ফলাফল ব্রাউজ করুন। প্রতিটি ফলাফল মার্কেটের ইম্প্লায়েড প্রবাবিলিটি প্রতিনিধিত্ব করে একটি বর্তমান দাম দেখায়। পজিশন নিতে, আপনি যে ফলাফলকে সবচেয়ে সম্ভাবনাময় মনে করেন সেটি নির্বাচন করুন, এর পক্ষে "Yes" বা বিপক্ষে "No" বেছে নিন, আপনার পরিমাণ লিখুন এবং "Trade" ক্লিক করুন। মার্কেট রেজলভ হলে আপনার নির্বাচিত ফলাফল সঠিক হলে, আপনার "Yes" শেয়ার প্রতিটি $1 দেয়। ভুল হলে, $0 দেয়।

"Alamar Biosciences IPO Closing Market Cap"-এর বর্তমান ফ্রন্টরানার "1.3B+" 100%-এ, মানে মার্কেট সেই ফলাফলে 100% সম্ভাবনা নির্ধারণ করে। পরবর্তী নিকটতম ফলাফল "<0.9B" 0%-এ। এই অডস রিয়েল-টাইমে আপডেট হয়।

"Alamar Biosciences IPO Closing Market Cap"-এর রেজোলিউশন নিয়ম সঠিকভাবে সংজ্ঞায়িত করে প্রতিটি ফলাফলকে বিজয়ী ঘোষণা করতে কী ঘটতে হবে — ফলাফল নির্ধারণে ব্যবহৃত অফিসিয়াল ডেটা সোর্স সহ। আপনি এই পেজের মন্তব্যের উপরে "Rules" সেকশনে সম্পূর্ণ রেজোলিউশন মানদণ্ড রিভিউ করতে পারেন।